Analysts Are Bullish on These Healthcare Stocks: Viridian Therapeutics (VRDN), Genfleet Therapeutics (Shanghai), Inc. Class H (HK:2595)

Viridian Therapeutics (VRDN)

In a report released yesterday, Laura Chico from Wedbush maintained a Buy rating on Viridian Therapeutics, with a price target of $32.00. The company’s shares closed last Friday at $17.90.

According to TipRanks.com, Chico is a 5-star analyst with an average return of 14.6% and a 54.5% success rate. Chico covers the Healthcare sector, focusing on stocks such as Praxis Precision Medicines, Sionna Therapeutics, Inc., and Ultragenyx Pharmaceutical.

Currently, the analyst consensus on Viridian Therapeutics is a Strong Buy with an average price target of $32.42.

See today’s best-performing stocks on TipRanks >>